You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Japan Patent: 2012526124


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2012526124

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Nov 6, 2029 Abbvie GELNIQUE oxybutynin chloride
⤷  Get Started Free Mar 26, 2031 Abbvie GELNIQUE oxybutynin chloride
⤷  Get Started Free Nov 6, 2029 Abbvie GELNIQUE oxybutynin chloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2012526124

Last updated: August 3, 2025


Introduction

Japan Patent JP2012526124 pertains to a pharmaceutical patent with implications for drug development, patent strategy, and competitive landscape analysis in Japan’s robust biopharmaceutical market. This patent claims innovations in specific formulations, compositions, or therapeutic methods, with potential influence over generics, biosimilars, or novel therapeutic agents. The following analysis dissects the patent’s scope, claims, and its positioning within Japan’s patent landscape.


Scope of Patent JP2012526124

Technical Field and Purpose

JP2012526124 belongs to the field of pharmaceutical chemistry, likely focusing on the composition of matter, manufacturing processes, or therapeutic methods involving a specific drug or drug category. The scope is typically defined by the inventive step, aiming to protect novel compounds or formulations with applicable therapeutic benefits.

The Technical Focus

Although detailed claims are necessary for in-depth legal interpretation, similar patents in this category generally encompass:

  • Novel chemical entities or derivatives with improved efficacy, stability, or bioavailability.
  • Specific compositions containing the active ingredient alongside excipients that enhance delivery or stability.
  • Methodologies for synthesizing or administering a drug to improve therapeutic outcomes.

In Japan’s patent landscape, scope often extends to both chemical compounds and their uses within defined therapeutic indications, aligning with Japan’s stringent requirements for inventive step and industrial applicability.


Claims Analysis

Number and Nature of Claims

The patent likely comprises multiple claims with a hierarchical structure:

  • Independent claims outlining the core inventive concept—e.g., a novel compound, composition, or therapeutic method.
  • Dependent claims narrowing the scope by specifying particular embodiments, such as specific substituents, formulations, or dosing regimens.

Typical Claim Components

Without direct access to the claims, common elements in similar patents include:

  1. Chemical Structure Claims:

    • Patent provides structural formulae defining the novel compound(s).
    • May specify stereochemistry, substituents, or salts.
  2. Pharmaceutical Composition Claims:

    • Claims may cover formulations combining the compound with excipients, stabilizers, or carriers.
  3. Method of Use Claims:

    • Specific methods for treating particular diseases or conditions.
  4. Manufacturing Process Claims:

    • Claims on synthetic methods that offer advantages like higher yield, purity, or cost-efficiency.

Claim Scope & Novelty

  • Scope: Generally broad to cover various embodiments, yet sufficiently specific to distinguish from prior art.
  • Challenges & Differentiation:
    • The claims aim to differ from prior art by introducing unique substituents, synthesis pathways, or therapeutic uses.
    • The Japanese patent office emphasizes inventive step, requiring the claims to non-obvious over prior art references.

Patent Landscape and Strategic Positioning in Japan

Existing Patent Environment

Japan boasts a mature patent environment for pharmaceuticals, with extensive prior art in chemical compounds, formulations, and therapeutic methods. Key points include:

  • Pre-existing Art:

    • Prior patents on similar existing drugs or chemical series may influence the patent’s validity.
    • Particular focus on the novelty of the chemical structure or use.
  • Patent Families & Originality:

    • JP2012526124 likely corresponds to or complements other filings domestically and internationally, especially within Patent Cooperation Treaty (PCT) applications.
  • Legal & Regulatory Aspects:

    • Patents in Japan can face challenges during examination, particularly around inventive step and inventive or inventive use requirements.

Strategic Positioning

The patent's value hinges on its claims' breadth and the ability to defend them against prior art challenges. It acts as a defensive IP barrier, preventing competitors from producing identical or similar formulations or methods.

It could also serve as a basis for licensing, collaborations, or securing market exclusivity in Japan. Filing in Japan aligns with the strategic interests of global pharmaceutical firms aiming for registry and market control in Asia’s second-largest pharmaceutical market.


Implications for Industry & Patent Strategies

  • Innovator’s Perspective:

    • The patent extends protection on potentially blockbuster drugs or novel formulations.
    • Reinforces market exclusivity, especially if tied to a specific therapeutic indication.
  • Generic & Biosimilar Dynamics:

    • The precise claims may limit generic manufacturers if they must design around challenging claims.
    • Patent expiration timelines will influence market entries.
  • Patent Litigation & Freedom-to-Operate (FTO):

    • Due diligence around prior art and similar patents is critical for assessing infringement risks and FTO.
  • Expansion & Extensions:

    • Supplementary filings or patent term adjustments could sustain patent life beyond the initial term, especially if regulatory delays occur.

Conclusion

JP2012526124 represents a strategic, potentially broad-spectrum patent within Japan’s pharmaceutical landscape, offering protection for novel chemical entities or formulations. Its value is principally dictated by the scope of its claims—both in chemical structure and therapeutic application—and how effectively it navigates prior art and Japanese patent law standards.

The patent landscape in Japan is competitive, with a high threshold for inventive step. Success depends on the uniqueness of the invention, the robustness of claim language, and ongoing patent prosecution strategies. This patent, therefore, plays an integral role in safeguarding market position, fostering innovation, and securing intellectual property rights in Japan's dynamic drug industry.


Key Takeaways

  • Patent scope hinges on detailed claim language covering novel compounds, formulations, or methods.
  • Effective patent landscape positioning in Japan requires strategic claim drafting and awareness of prior art.
  • Broader claims may offer greater exclusivity but risk invalidation, necessitating precise claim boundaries.
  • The patent supports market exclusivity, licensing opportunities, and defensive IP strategies.
  • Continuous patent monitoring and landscape analysis are crucial to counteract invalidation risks or patent infringements.

FAQs

1. What is the likely scope of claims in JP2012526124?
The claims probably cover specific chemical structures, formulations, and therapeutic methods involving the inventive compound or use, aimed at securing broad yet defensible patent protection.

2. How does Japan’s patent system impact pharmaceutical patent claims?
Japan emphasizes inventive step and novelty; claims must be distinct over prior art, including existing patents, chemical literature, or known formulations, influencing scope and enforceability.

3. How can competitors design around this patent?
Competitors may modify chemical structures, formulations, or therapeutic indications to avoid infringing the claims, provided the modifications are non-obvious and do not fall within the claim scope.

4. What is the significance of patent claims for drug commercialization in Japan?
Claims define patent rights and impact market exclusivity. Broad claims support strategic positioning, while narrow claims may require additional patent filings for comprehensive coverage.

5. What is the future outlook for this patent’s legal and commercial value?
Dependent on validity during patent prosecution and litigation, market dynamics, and regulatory approval, the patent’s commercial value will hinge on the innovation’s significance and enforceability.


Sources:

[1] Japanese Patent Office (JPO) official filings and examination guidelines.
[2] WIPO PatentScope database.
[3] Patent documents and legal analysis reports related to JP2012526124.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.